{"id":"W3186824000","doi":"10.1038/s41375-021-01342-x","title":"Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202","year":2021,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Ibrutinib; Bendamustine; Medicine; Internal medicine; Adverse effect; Rituximab; Cumulative incidence; Gastroenterology; Chronic lymphocytic leukemia; Lymphoma; Leukemia; Cohort","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003675049,0.0003813222,0.0007298783,0.0001401737,0.00009828654,0.00003514036,0.000269592,0.0002457559,0.001490051],"category_scores_gemma":[0.0008704326,0.0002995966,0.0001208116,0.001018011,0.0001520852,0.0002057681,0.0002866758,0.000726395,0.0003048001],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.03454647,"about_ca_system_score_gemma":0.02032461,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001217508,"about_ca_topic_score_gemma":0.0007259048,"domain_scores_codex":[0.9961932,0.0001308931,0.0006564457,0.0009146079,0.00113425,0.0009705717],"domain_scores_gemma":[0.9977398,0.0002830446,0.0001761364,0.001035316,0.0004065121,0.0003592169],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.0819399,0.01247084,0.2423445,0.02049975,0.004300042,0.1421995,0.04234999,0.04024638,0.006755948,0.001218796,0.2305906,0.1750837],"study_design_scores_gemma":[0.5453992,0.002170118,0.2462415,0.01437193,0.0005902958,0.001702795,0.003709174,0.0660513,0.007275331,0.00009579311,0.1099127,0.002479899],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925845,0.00055741,0.00009036926,0.0008464867,0.0002279467,0.001078976,0.0000244896,0.0001146513,0.004475229],"genre_scores_gemma":[0.9708624,0.0002489341,0.003098106,0.0007441237,0.0003658702,0.0001104412,0.0002117861,0.0001076435,0.02425063],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4634593,"threshold_uncertainty_score":0.9999456,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01812285946345379,"score_gpt":0.2906093089517058,"score_spread":0.2724864494882521,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}